Challenging regional psoriasis and ustekinumab biotherapy: Impact of the patterns of disease

Trinh Hermanns-Lê, Enzo Berardesca, Gérald E. Piérard, Marianne Lesuisse, Claudine Piérard-Franchimont

Research output: Contribution to journalArticle

Abstract

In some patients, psoriasis appears refractory to many treatments, particularly when the disease is confined to some specific body regions. In this respect, palmoplantar psoriasis and palmoplantar pustulosis are possibly related conditions in their immunopathomechanisms involving Il-12, IL-23, and Th17. Nail psoriasis and scalp psoriasis are two other particular psoriasis manifestations. Accordingly, ustekinumab was tested in a few of these patients. The present paper is limited to peer-reviewed case reports. Data were not supported by bioinstrumental assessments and controlled trials. Overall, they are indicative of potential efficacy. The cost-effectiveness and the risk-benefit assessments merit further investigations.

Original languageEnglish
Article number413767
JournalJournal of Biomedicine and Biotechnology
Volume2012
DOIs
Publication statusPublished - 2012

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Genetics
  • Molecular Biology
  • Health, Toxicology and Mutagenesis
  • Medicine(all)

Fingerprint Dive into the research topics of 'Challenging regional psoriasis and ustekinumab biotherapy: Impact of the patterns of disease'. Together they form a unique fingerprint.

  • Cite this

    Hermanns-Lê, T., Berardesca, E., Piérard, G. E., Lesuisse, M., & Piérard-Franchimont, C. (2012). Challenging regional psoriasis and ustekinumab biotherapy: Impact of the patterns of disease. Journal of Biomedicine and Biotechnology, 2012, [413767]. https://doi.org/10.1155/2012/413767